iRadimed Corporation (IRMD)
NASDAQ
85.82
-1.82 (-2.08%)
Closed
Oct 23, 2026
Day's Range
85.4687.90
52 wk Range
75.75107.90
Financial Statements - IRMD - iRadimed Corporation
Revenue
83.81M▲ 14.4%
Net Income
22.48M▲ 16.9%Net Margin 26.8%
EBITDA
27.10M▲ 18.7%
Free Cash Flow
16.52M▼ 1.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 83.81M | 73.24M | 65.56M | 53.30M | 41.81M | 31.71M |
| Cost of Goods | 19.49M | 16.89M | 15.40M | 12.02M | 9.76M | 8.14M |
| Gross Profit | 64.32M | 56.34M | 50.15M | 41.28M | 32.04M | 23.57M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 26.14M | 21.96M | 20.03M | 15.62M | 9.81M | -756.09K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 205K | 117.58K | -161.31K | -28.74K | -16.20K | 7.02K |
| Pre Tax Income | 28.36M | 24.27M | 21.73M | 16.18M | 9.83M | -616.87K |
| Income Tax | 5.88M | 5.04M | 4.54M | 3.35M | 510.81K | -1.98M |
| Net Income | 22.48M | 19.23M | 17.19M | 12.82M | 9.32M | 1.36M |
| EPS Basic | 1.77 | 1.52 | 1.36 | 1.02 | 0.76 | 0.11 |
| EPS Diluted | 1.75 | 1.5 | 1.35 | 1.02 | 0.74 | 0.11 |
| Basic Shares Outstanding | 12.72M | 12.67M | 12.60M | 12.56M | 12.34M | 12.12M |
| Diluted Shares Outstanding | 12.72M | 12.67M | 12.60M | 12.56M | 12.34M | 12.12M |
| Ebit | 26.14M | 21.96M | 20.03M | 15.62M | 9.81M | -756.09K |
| Ebitda | 27.10M | 22.82M | 20.96M | 16.32M | 11.24M | 575.70K |
| Net Income Continuous Operations | 22.48M | 19.23M | 17.19M | 12.82M | 9.32M | 1.36M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
